Published in Urology on May 01, 1998
Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol (2003) 3.73
Combined pre- and postoperative adjuvant radiation therapy for bladder cancer--a ten year experience. Int J Radiat Oncol Biol Phys (1992) 2.24
Inbreeding effects on fertility in humans: evidence for reproductive compensation. Am J Hum Genet (1999) 2.17
DNA-dependent protein kinase stimulates an independently active, nonhomologous, end-joining apparatus. Cancer Res (2000) 1.97
Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res (1992) 1.75
Prognostic significance of high-grade dysplasia in colorectal adenomas. Colorectal Dis (2011) 1.45
Clinical and US findings in prostate cancer: patients with normal prostate-specific antigen levels. Radiology (1993) 1.42
Human leukocyte antigen matching and fetal loss: results of a 10 year prospective study. Hum Reprod (1998) 1.38
Use of cancer susceptibility testing among primary care physicians. Clin Genet (2003) 1.30
The urinary glycoprotein GP51 as a clinical marker for interstitial cystitis. J Urol (1999) 1.28
The primary antibacterial defense mechanism of the bladder. Invest Urol (1975) 1.24
Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: support for dose escalation based on a biological model. J Urol (1997) 1.20
Role of surface mucin in primary antibacterial defense of bladder. Urology (1977) 1.19
Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer (2000) 1.18
Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1. Cancer Res (1993) 1.18
Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer. J Clin Oncol (1997) 1.16
Hospital-acquired urinary tract infections associated with the indwelling catheter. Urol Clin North Am (1999) 1.13
Functional vision is improved in the majority of patients treated with external-beam radiotherapy for choroid metastases: a multivariate analysis of 188 patients. J Clin Oncol (1997) 1.13
External beam irradiation for choroid metastases: identification of factors predisposing to long-term sequelae. Int J Radiat Oncol Biol Phys (1997) 1.12
Successful therapy of interstitial cystitis with pentosanpolysulfate. J Urol (1987) 1.11
Physician intention to recommend complete diagnostic evaluation in colorectal cancer screening. Cancer Epidemiol Biomarkers Prev (1999) 1.10
Antibacterial activity of bladder surface mucin duplicated by exogenous glycosaminoglycan (heparin). Infect Immun (1979) 1.09
Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer: the importance of radiation dose. Urology (1998) 1.06
Familial pheochromocytoma associated with cerebellar hemangioblastoma. A case history and review of the literature. JAMA (1969) 1.04
Effect of higher radiation dose on biochemical control after radical prostatectomy for PT3N0 prostate cancer. Int J Radiat Oncol Biol Phys (1998) 1.04
Bladder surface mucin. Examination of possible mechanisms for its antibacterial effect. Invest Urol (1978) 1.04
The multidisciplinary clinic approach to prostate cancer counseling and treatment. Semin Urol Oncol (2000) 1.02
Subject-by-formulation interaction in bioequivalence: conceptual and statistical issues. FDA Population/Individual Bioequivalence Working Group. Food and Drug Administration. Pharm Res (2000) 1.02
Complete diagnostic evaluation in colorectal cancer screening: research design and baseline findings. Prev Med (2001) 1.02
Cytokine patterns during progression to AIDS in children with perinatal HIV infection. J Immunol (1995) 1.01
Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder. J Urol (1997) 1.00
Intention to be tested for prostate cancer risk among African-American men. Cancer Epidemiol Biomarkers Prev (2000) 0.99
Clinically occult Leydig cell tumor presenting with gynecomastia. J Urol (1989) 0.98
Bladder surface mucin. Its antibacterial effect against various bacterial species. Am J Pathol (1978) 0.97
Muscle sodium channel inactivation defect in paramyotonia congenita with the thr1313met mutation. Neuromuscul Disord (1995) 0.96
Effect of ammonium on bacterial adherence to bladder transitional epithelium. J Urol (1984) 0.95
Measuring complete diagnostic evaluation in colorectal cancer screening. Cancer Detect Prev (2001) 0.95
Role of urothelial surface mucoprotein in intrinsic bladder defense. Urology (1977) 0.94
The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys (1999) 0.93
Paclitaxel plus estramustine in metastatic hormone-refractory prostate cancer. Semin Oncol (1995) 0.90
Phase i study of intravesical vaccinia virus as a vector for gene therapy of bladder cancer. J Urol (2001) 0.90
A study of hospital urinary tract infections. J Urol (1973) 0.90
c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells. Leukemia (2011) 0.89
Does hormonal therapy influence sexual function in men receiving 3D conformal radiation therapy for prostate cancer? Int J Radiat Oncol Biol Phys (2001) 0.89
Experience with detailed surveillance of nosocomial infection. Surg Gynecol Obstet (1975) 0.88
The protective effect of heparin in experimental bladder infection. J Surg Res (1978) 0.88
Segmental polycystic disease. N Y State J Med (1972) 0.88
Etiology of infertility after retroperitoneal lymphadenectomy. J Urol (1971) 0.87
The effect of rabbit vesical mucosa on bacterial growth. Invest Urol (1969) 0.87
Ultrasonic detection of nonopaque renal calculi. Radiology (1978) 0.87
Ureteral ectopia presenting as epididymitis and infertility. Urology (1987) 0.86
Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection. Urology (1995) 0.84
Polymorphisms in adenosine receptor genes are associated with infarct size in patients with ischemic cardiomyopathy. Clin Pharmacol Ther (2007) 0.84
Poxvirus vectors: orphaned and underappreciated. J Clin Invest (2000) 0.84
Peanut lectin binding sites in transitional cell carcinoma of the urinary bladder. Cancer (1984) 0.83
African-American men and intention to adhere to recommended follow-up for an abnormal prostate cancer early detection examination result. Urology (2000) 0.83
Overexpression of p21WAF1/CIP1 and MDM2 characterizes serous borderline ovarian tumors. Hum Pathol (2000) 0.83
In vitro sealing of punctured fetal membranes: potential treatment for midtrimester premature rupture of membranes. Am J Obstet Gynecol (2001) 0.83
Vesical defense: assessment of adsorption potential with live, dead, and metabolically inhibited Escherichia coli and 99mTC-labeled sulfur colloid particles. Surg Forum (1977) 0.83
Generalized treatment effects for clinical trials. Stat Med (2000) 0.81
The effect of intermittent pneumatic compression devices on intraoperative blood loss during radical prostatectomy and radical cystectomy. J Urol (1993) 0.81
Analysis and significance of nosocomial infection rates. Ann Surg (1974) 0.81
The antibacterial properties of urine. Invest Urol (1969) 0.81
The effect of trichomonal vaginitis on vaginal pH. J Urol (1977) 0.80
Controversies in management of urinary tract infection. Urology (1986) 0.80
The invention of the modern uroflowmeter by Willard M. Drake, Jr at Jefferson Medical College. Urology (1998) 0.80
Hyperplastic ductal and lobular lesions and carcinomas in situ of the breast: reproducibility of current diagnostic criteria among community- and academic-based pathologists. Breast J (1998) 0.79
Interaction of bladder glycoprotein GP51 with uropathogenic bacteria. J Urol (2001) 0.79
An individual bioequivalence criterion: regulatory considerations. Stat Med (2000) 0.79
Effect of hormonal deprivation on the bladder defense mechanism. J Urol (1982) 0.78
Vesical defense: further evidence for a charge-related mucosal anti-adherence mechanism. Surg Forum (1978) 0.78
Antibacterial activity of rat vesical mucosa. J Urol (1970) 0.78
Urinary tract infections and P blood group antigens. Urology (1984) 0.78
Changes in the size and location of kidneys from the supine to standing positions and the implications for block placement during total body irradiation. Int J Radiat Oncol Biol Phys (1999) 0.78
Antibiotic sensitivity of isolates from nosocomial and community-acquired urinary tract infections. Urology (1973) 0.78
ABH isoantigens in stage O papillary transitional cell carcinoma of the bladder: correlation with biological behavior. J Urol (1982) 0.78
The production of antibodies to pentosanpolysulfate (ELMIRON, SP-54). J Immunol Methods (1991) 0.78
National trends in the surgical staging of corpus cancer: a pattern-of-practice survey. Obstet Gynecol (1997) 0.77
Heparin as antibacterial agent in rabbit bladder. Urology (1978) 0.77
Radiation Therapy Oncology Group. Research Plan 2002-2006. Genitourinary Cancer Committee. Int J Radiat Oncol Biol Phys (2001) 0.77
Ultrasound-guided four quadrant biopsy of the prostate: efficacy in the diagnosis of isoechoic cancer. Clin Radiol (1994) 0.77
Heparin--examination of its antibacterial adsorption properties. Urology (1981) 0.77
Prospective clinical evaluation of an electronic portal imaging device. Int J Radiat Oncol Biol Phys (1996) 0.77
The presence of an antibacterial glycoprotein in a spectrum of transitional gel carcinomas. J Urol (1992) 0.77
Postoperative epidural analgesia following radical retropubic prostatectomy: outcome assessment. J Surg Oncol (1998) 0.77
Induction androgen deprivation plus prostatectomy for stage T3 disease: failure to achieve prostate-specific antigen-based freedom from disease status in a phase II trial. Urology (1996) 0.76
Long-term outcome following sympathectomy for complex regional pain syndrome type 1 (RSD). J Neurol Sci (1997) 0.76
Screening for occult nodal metastasis in localized carcinoma of the prostate. J Urol (1993) 0.76
Postoperative radiation therapy after radical prostatectomy for prostate carcinoma. Cancer (1993) 0.75
A simple, inexpensive semi-continuous or continuous culture apparatus. J Clin Pathol (1972) 0.75
Quantitative verification of 192Ir PDR and HDR source structure by pin-hole autoradiography. Med Phys (1995) 0.75
Is there a role for antibiotic prophylaxis in transperineal interstitial permanent prostate brachytherapy? Tech Urol (2000) 0.75
Intracavitary brachytherapy for squamous cell carcinoma of the esophagus. Am J Clin Oncol (1994) 0.75
Primary nonfunctioning adrenal tumors in adults. Urology (1981) 0.75
An evaluation of two methods of anatomical alignment of radiotherapy portal images. Int J Radiat Oncol Biol Phys (1993) 0.75
An analysis of intratreatment and intertreatment displacements in pelvic radiotherapy using electronic portal imaging. Int J Radiat Oncol Biol Phys (1996) 0.75
Radiation Therapy Oncology Group. Research Plan 2002-2006. Surgical Oncology Committee. Int J Radiat Oncol Biol Phys (2001) 0.75
Concomitant irradiation and dose-escalating carboplatin for locally advanced carcinoma of the uterine cervix: an updated report. Am J Clin Oncol (1998) 0.75